All News Novavax, Inc.

Equities

NVAX

US6700024010

Real-time Estimate Cboe BZX Other stock markets 12:25:55 2024-06-10 pm EDT			5-day change	1st Jan Change
15.65 ^USD	-13.87%		-14.05%	+226.25%

Jun. 07	COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says	RE
Jun. 06	S&P 500, Nasdaq dip on the eve of US payrolls data	RE

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says	Jun. 07	RE
S&P 500, Nasdaq dip on the eve of US payrolls data	Jun. 06	RE
Wall Street mixed as Nvidia retreat hits tech stocks; payrolls data in focus	Jun. 06	RE
Novavax Says FDA Review Target Date Set for Covid-19 Vaccine Biologics License Application	Jun. 06	MT
Novavax Prepared to Deliver JN.1 Protein-based Non-mRNA COVID-19 Vaccine This Fall Consistent with U.S. FDA VRBPAC Recommendation	Jun. 06	AQ
Peraso Inc. (NASDAQ: PRSO) Announces Paradigm-Shifting mmWave Wi-Fi Advancements with Phased Array Antenna Technology	Jun. 06	AQ
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines	Jun. 05	AQ
Novavax Says It Can Deliver Recommended Covid Vaccine in September	Jun. 05	DJ
Novavax : Prepared to Deliver JN.1 Protein based Non mRNA COVID 19 Vaccine This Fall Consistent with U.S. FDA VRBPAC Recommendation	Jun. 05	PU
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say	Jun. 05	RE
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says	Jun. 03	RE
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns	May. 30	AQ
Novavax to Participate in 2024 Jefferies Global Healthcare Conference	May. 30	PR
Sanofi and Novavax Announce Co-Exclusive Licensing Agreement to Co-Commercialize Covid-19 Vaccine and Develop Novel Flu-Covid-19 Combination Vaccines	May. 28	CI
Novavax awaits FDA decision on whether its next COVID shot can be offered in US	May. 24	RE
Novavax, Inc. Notifies Retirement of Filip Dubovsky as President, Research and Development, Effective as of June 30, 2024	May. 23	CI
B. Riley Boosts Price Target on Novavax to $29 From $11, Maintains Buy Rating	May. 23	MT
Novavax: 1st shipment of R21/MatrixM malaria vaccine	May. 21	CF
Serum Institute of India Ships Its First Set of R21/Matrix-M? Malaria Vaccine Doses to Africa [press release]	May. 20	AQ
Global markets live: Apple, Tesla, Pfizer, AstraZeneca, Microsoft...	May. 20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novavax Surges on $1.2 Billion Sanofi Vaccine Deal

May 10, 2024 at 02:52 pm EDT